NEBBIOSO, Angela
 Distribuzione geografica
Continente #
EU - Europa 10.433
NA - Nord America 6.201
AS - Asia 4.330
SA - Sud America 724
Continente sconosciuto - Info sul continente non disponibili 332
AF - Africa 67
OC - Oceania 7
Totale 22.094
Nazione #
RU - Federazione Russa 6.345
US - Stati Uniti d'America 6.014
SG - Singapore 1.485
IT - Italia 1.269
IE - Irlanda 1.057
CN - Cina 918
HK - Hong Kong 696
BR - Brasile 611
VN - Vietnam 491
GB - Regno Unito 405
UA - Ucraina 395
DE - Germania 343
KR - Corea 226
IN - India 125
FI - Finlandia 122
SE - Svezia 114
FR - Francia 86
GR - Grecia 84
TR - Turchia 83
CA - Canada 77
BD - Bangladesh 71
JP - Giappone 57
AR - Argentina 50
NL - Olanda 44
MX - Messico 40
PK - Pakistan 35
BE - Belgio 23
ID - Indonesia 23
IQ - Iraq 23
ZA - Sudafrica 22
AT - Austria 21
PL - Polonia 20
CR - Costa Rica 17
EC - Ecuador 17
ES - Italia 17
UZ - Uzbekistan 15
CO - Colombia 13
HU - Ungheria 11
JM - Giamaica 11
MA - Marocco 11
VE - Venezuela 10
LT - Lituania 9
RO - Romania 9
CL - Cile 8
MY - Malesia 8
PT - Portogallo 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
BG - Bulgaria 6
GT - Guatemala 6
HN - Honduras 6
IL - Israele 6
PH - Filippine 6
SA - Arabia Saudita 6
TT - Trinidad e Tobago 6
AL - Albania 5
AZ - Azerbaigian 5
BS - Bahamas 5
EG - Egitto 5
ET - Etiopia 5
EU - Europa 5
LV - Lettonia 5
NO - Norvegia 5
NP - Nepal 5
SI - Slovenia 5
SV - El Salvador 5
AU - Australia 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
DZ - Algeria 4
IR - Iran 4
KE - Kenya 4
KZ - Kazakistan 4
PE - Perù 4
PR - Porto Rico 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
BB - Barbados 3
BO - Bolivia 3
CW - ???statistics.table.value.countryCode.CW??? 3
HR - Croazia 3
OM - Oman 3
PY - Paraguay 3
TW - Taiwan 3
UY - Uruguay 3
BW - Botswana 2
GP - Guadalupe 2
JO - Giordania 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LC - Santa Lucia 2
LK - Sri Lanka 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
AM - Armenia 1
Totale 21.755
Città #
Moscow 2.257
Dublin 1.056
Singapore 732
Hong Kong 681
Santa Clara 674
San Jose 634
Jacksonville 605
Chandler 499
Ashburn 456
Council Bluffs 326
Seoul 214
Beijing 204
Caserta 172
Ho Chi Minh City 147
Naples 145
Princeton 139
Milan 126
Medford 116
Hefei 113
Hanoi 112
Ann Arbor 99
Boardman 91
Roxbury 85
New York 72
Dallas 67
Bengaluru 65
Munich 65
Wilmington 64
São Paulo 63
Bremen 62
The Dalles 60
Los Angeles 57
San Mateo 52
Rome 50
Aversa 46
Napoli 42
Orem 38
Woodbridge 35
Cambridge 33
Da Nang 33
Rio de Janeiro 33
Atlanta 30
Dong Ket 30
North Bergen 30
Des Moines 29
Miano 28
Nuremberg 26
Chicago 25
Haiphong 24
Brussels 23
Nanjing 23
Mountain View 22
Amsterdam 20
Brooklyn 20
Norwalk 20
Houston 19
Memphis 19
Boston 17
Jinan 17
Warsaw 17
Düsseldorf 16
Frankfurt am Main 16
Giugliano in Campania 16
Redwood City 16
London 15
Phoenix 15
Salvador 15
San José 15
Biên Hòa 14
Florence 14
Tianjin 14
Turku 14
Guangzhou 13
Montreal 13
Tashkent 13
Vienna 13
Chennai 12
Denver 12
Mexico City 12
Ercolano 11
Ferrara 11
Lappeenranta 11
Seattle 11
Belo Horizonte 10
Buenos Aires 10
Changsha 10
Hangzhou 10
Helsinki 10
Hillsboro 10
Nanchang 10
Paris 10
Thái Nguyên 10
Auburn Hills 9
Bologna 9
Brasília 9
Hải Dương 9
Johannesburg 9
Kingston 9
Miami 9
Mumbai 9
Totale 11.533
Nome #
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 302
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 230
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondria! Function and Exhibit Inhibition of Proliferation in Cancer Cells 219
The clinical value of HDAC2 and the p53-dependent signalling pathway in colorectal cancer 212
Anticancer activities of anthocyanin extract from genotyped Solanum tuberosum L. "Vitelotte" 212
Antiproliferative, antibacterial and antifungal activity of the lichen Xanthoria parietina and its secondary metabolite parietin 209
Forskolin potentiates the effects of GSKJ4 in human acute myeloid leukemia cells through Protein Kinase A pathway 207
1,3,4-oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells. 196
Molecular Profiling of Human Primary Chondrosarcoma-Derived Spheres Reveals Specific and Target Genes Involved in Multidrug Resistance and Metastasis 192
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer 191
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway 188
CBX3 as a prognostic biomarker in lung cancer 187
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities 186
Analysis of chromatin-nuclear receptor interactions by laser-chromatin immunoprecipitation. 183
Different Approaches to Unveil Biomolecule Configurations and Their Mutual Interactions 182
Characterization of Histone Acetyltransferase-1 in cancer cells 181
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias. 178
ATTIVITÀ ANTI-PROLIFERATIVA E DIFFERENZIANTE INDOTTA DAL FRUTTO DI PSIDIUM GUAJAVA IN CELLULE LEUCEMICHE UMANE 178
Interplay between m6 A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives 175
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells 175
Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells 170
Combined HAT/EZH2 modulation leads to cancer-selective cell death 169
Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer 167
APOPTOSI INDOTTA DALL' ESTRATTO TOTALE ACETONICO DEL FRUTTO DI FEIJOA SELLOWIANA (BERG) IN CELLULE LEUCEMICHE UMANE 166
Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence 166
Cytotoxic Potential of the Marine Diatom Thalassiosira rotula: Insights into Bioactivity of 24-Methylene Cholesterol 163
Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1 162
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392. 162
BARD1 is a target of miR-19a and miR-19b: a new selective epigenetic therapy for acute myeloid lekaemias? 162
Comparative phytochemical characterization, genetic profile, and antiproliferative activity of polyphenol-rich extracts from pigmented tubers of different solanum tuberosum varieties 162
ATTIVITA’ ANTITUMORALE DEL FLAVONE NATURALE PURIFICATO DA FEIJOA SELLOWIANA IN CELLULE DI LEUCEMIA MIELOIDE ACUTA 158
The m6A-independent role of epitranscriptomic factors in cancer 156
3-Chloro-N '-(2-hydroxybenzylidene)benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy 156
Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer 155
The role of SAHA in boron uptake: harnessing epigenetic regulation of LAT1 for optimized BNCT 153
RIPK1-targeting in cancer: modulation of programmed cell death process for cancer treatment 152
TNF-related apoptosis-inducing ligand: Signalling of a 'smart' molecule 151
Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1. 151
"Stockpile" of Slight Transcriptomic Changes Determines the Indirect Genotoxicity of Low-Dose BPA in Thyroid Cells 151
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses 151
BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition 151
Targeting ROS production through inhibition of NADPH oxidases 150
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. 149
EPIGENETIC MODULATION OF LAT1 EXPRESSION TO ENHANCE OSTEOSARCOMA SENSITIVITY TO BORON NEUTRON CAPTURE THERAPY (BNCT) 148
Acute myeloid leukemia: Therapeutic impact of epigenetic drugs 148
Natural compounds in epigenetics: A current view. 147
Biological interactions of biocompatible and water-dispersed MoS2 nanosheets with bacteria and human cells 147
Cardioprotective effect of a moderate and prolonged exercise training involves sirtuin pathway. 147
The Role of Ozone Carried by Liposomes in the Therapy of Infectious and Skin-Regenerating Ocular Surface 147
Designing Novel Dual Transglutaminase 2 / Histone Deacetylase Inhibitors Effective in Halting Neuronal Death 146
ATTIVATORI DI SIRTUINE E LORO USI 146
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes 145
AZIONE "TUMORE-SELETTIVA" DEGLI INIBITORI DELLE ISTONE DEACETILASI IN LEUCEMIE MIELOIDI ACUTE 145
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease 145
Developing novel non-hydroxamate histone deacetylase inhibitors: The chelidamic warhead 143
PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia 142
Le basi cellulari e molecolari delle malattie per le lauree triennali e magistrali 142
Gene transactivation and transrepression in myc-driven cancers 142
SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism 142
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows 142
Novel cinnamyl hydroxyamides and 2-aminoanilides as histone deacetylase inhibitors: apoptotic induction and cytodifferentiation activity 141
Therapeutic Potential of Natural Compounds Acting through Epigenetic Mechanisms in Cardiovascular Diseases: Current Findings and Future Directions 140
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability 139
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexia 138
FEIJOA SELLOWIANA DERIVED NATURAL FLAVONE EXERTS ANTI-CANCER ACTION DISPLAYING HDAC INHIBITORY ACTIVITIES 138
Bispyridinium Dienes, Histone Deacetylase Inhibitors With Selective Activities 137
Cancer epigenetics: Moving forward 137
Identification of NuRSERY, a New Functional HDAC Complex Composed by HDAC5, GATA1, EKLF and pERK Present in Human Erythroid Cells. 136
Synthesis and Biological Validation of Novel Synthetic Histone/Protein Methyltransferase Inhibitors 136
Unravelling the impact of the chromobox proteins in human cancers 135
2-Substituted 1,5-benzothiazepine-based HDAC inhibitors exert anticancer activities on human solid and acute myeloid leukemia cell lines 133
Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors 133
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring. 133
The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia 131
KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches 131
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis 131
Sirtuin Inhibitor Cambinol Induces Cell Differentiation and Differently Interferes with SIRT1 and 2 at the Substrate Binding Site 130
The Pan-Sirtuin Inhibitor MC2494 Regulates Mitochondrial Function in a Leukemia Cell Line 130
Modulators of Sirtuins 129
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells 129
Epigenetic profiling of the antitumor natural product psammaplin A and its analogues 129
Forskolin sensitizes human acute myeloid leukemia cells to H3K27me2/3 demethylases GSKJ4 inhibitor via Protein Kinase A 129
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells 128
N{varepsilon}-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heart 128
RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer 127
A New Family of Jumonji C Domain-Containing KDM Inhibitors Inspired by Natural Product Purpurogallin 127
Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors 126
Indole-derived Psammaplin A Analogs as Epigenetic Modulators With Multiple Inhibitory Activities. 126
Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation 125
Identification of two New Synthetic Histone Deacetylase Inhibitors that Modulate Globin Gene Expression in Erythroid Cells from Normal Donors and Thalassemic Patients 124
Evaluation of a large library of (thiazol-2-yl)hydrazones and analogues as histone acetyltransferase inhibitors: enzyme and cellular studies. 124
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia. 123
SIRT1 Activation by Natural Phytochemicals: An Overview 123
HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b. 122
Identification and characterization of PKF118-310 as a KDM4A inhibitor 122
Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure-Activity Relationship, X-ray Crystal Structure, and Anticancer Activity 122
Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome 121
Pyrrole-Based Hydroxamates and 2-Aminoanilides: Histone Deacetylase Inhibition and Cellular Activities 120
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect 119
In-Depth Exploration of Radiation-Induced Cell Death Mechanisms in Tumor 119
Totale 15.251
Categoria #
all - tutte 74.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.382


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022762 0 0 0 38 279 13 16 24 38 39 59 256
2022/20232.004 161 57 52 159 204 155 1 92 993 14 50 66
2023/2024772 77 26 37 60 240 76 23 25 4 10 69 125
2024/20252.579 32 25 90 78 407 356 454 234 238 282 203 180
2025/202611.070 470 531 497 632 856 5.938 576 454 410 284 243 179
2026/20272.053 131 436 687 799 0 0 0 0 0 0 0 0
Totale 22.094